Urogen Pharma Share Price (NASDAQ: URGN)
$19.49
▲
0.99
(5.35%)
Last updated on
Check the interactive Urogen Pharma Stock chart to analyse performance
Urogen Pharma stock performance
as on August 27, 2025 at 1:29 AM IST
- Today's Low:$18.76Today's High:$19.49
3.75%
Downside
Day's Volatility :3.75%
Upside
0.0%
- 52 Weeks Low:$3.4252 Weeks High:$21.02
82.45%
Downside
52 Weeks Volatility :83.73%
Upside
7.26%
Urogen Pharma Stock Returns
Urogen Pharma Ltd Key Stats
Check Urogen Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Urogen Pharma Stock including INR - Dollar returns
The Urogen Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Urogen Pharma investment value today
Current value as on today
₹1,40,916
Returns
₹40,916
(+40.92%)
Returns from Urogen Pharma Stock
₹36,389 (+36.39%)
Dollar Returns*
₹4,527 (+4.53%)
Indian investors sentiment towards Urogen Pharma Stock
Global Institutional Holdings in Urogen Pharma Ltd
Name
Holdings %
RTW INVESTMENTS, LLC
9.82%
The Toronto-Dominion Bank
6.90%
BlackRock Inc
5.24%
MENORA MIVTACHIM HOLDINGS LIMITED
4.98%
Soleus Capital Management, L.P.
4.72%
Vestal Point Capital LP
4.65%
Analyst Recommendation on Urogen Pharma Stock
Buy
81%Buy
18%Hold
0%Sell
Based on 11 Wall street analysts offering stock ratings for Urogen Pharma(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Urogen Pharma Share Price Target
What analysts predicted
Upside of 64.19%
Target:
$32.00
Current:
$19.49
Urogen Pharma share price target is $32.00, a slight Upside of 64.19% compared to current price of $19.49 as per analysts' prediction.
Urogen Pharma Stock Insights
Price Movement
In the last 3 months, URGN stock has moved up by 341.8%Increasing Revenue
Revenue is up for the last 2 quarters, 20.25M → 24.21M (in $), with an average increase of 16.4% per quarterDecreasing Net Profit
Netprofit is down for the last 4 quarters, -23.67M → -49.94M (in $), with an average decrease of 29.8% per quarterURGN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 64.8% return, outperforming this stock by 35.3%Price to Sales
ForURGN every $1 of sales, investors are willing to pay $9.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.
Urogen Pharma Ltd Financials
Urogen Pharma Technicals Summary
Sell
Neutral
Buy
Urogen Pharma is currently in a neutral trading position according to technical analysis indicators.
Urogen Pharma Ltd Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -2.06% | 97.76% | 29.71% | 140.08% | -16.96% |
 | 2.56% | -18.96% | -52.33% | -3.35% | -4.93% |
 | 5.47% | 19.93% | 53.65% | 85.67% | 27.85% |
 | -15.59% | -18.81% | -19.02% | 38.13% | 44.08% |
 | 36.58% | 81.91% | 58.28% | 112.22% | 237.57% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | -2.99 | -14.81 | -0.31 | NA | -2.02 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 28.08 | 28.08 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $899.4M | -16.96% | NA | -164.44% |
| Buy | $62.5B | -4.93% | 14.86 | 31.37% |
| NA | $38.3B | 27.85% | NA | -3.89% |
| Buy | $101.3B | 44.08% | 28.08 | 31.86% |
| Buy | $59.6B | 237.57% | NA | -12.96% |
About Urogen Pharma Ltd
Key Management of Urogen Pharma Ltd
Important FAQs about investing in URGN Stock from India :
What is Urogen Pharma share price today?
Urogen Pharma share price today is $19.49 as on at the close of the market. Urogen Pharma share today touched a day high of $19.49 and a low of $18.76.
What is the 52 week high and 52 week low for Urogen Pharma share?
Urogen Pharma share touched a 52 week high of $21.02 and a 52 week low of $3.42. Urogen Pharma stock price today i.e. is closed at $19.49, lower by 7.26% versus the 52 week high.
How to invest in Urogen Pharma Stock (URGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Urogen Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Urogen Pharma Shares that will get you 0.0770 shares as per Urogen Pharma share price of $19.49 per share as on August 27, 2025 at 1:29 AM IST.
What is the minimum amount required to buy Urogen Pharma Stock (URGN) from India?
Indian investors can start investing in Urogen Pharma (URGN) shares with as little as ₹87.6525 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹876.53 in Urogen Pharma stock (as per the Rupee-Dollar exchange rate as on August 27, 2025).
Based on Urogen Pharma share’s latest price of $19.49 as on August 27, 2025 at 1:29 AM IST, you will get 0.5131 shares of Urogen Pharma. Learn more about
fractional shares .
What are the returns that Urogen Pharma has given to Indian investors in the last 5 years?
Urogen Pharma stock has given -16.96% share price returns and 18.61% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Wisdomtree Smallcap Earnings Etf$55.59
+0.23%
- Vaneck Mstar Gl Wide Moat
$44.30
-0.14%
Sprout Social Inc$15.23
+4.03%
- Aam Brentview Dividend Growth Etf
$21.54
-0.51%
- Horizon Digital Frontier Etf
$25.75
-0.31%
- Composecure Inc
$19.80
+0.76%
- Ishares Msci Norway Etf
$28.35
+0.25%
- Atac Us Rotation Etf
$15.57
+0.06%
Redhill Biopharma Ltd-sp Adr$1.37
+0.0%